We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 12 investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
ExpoCart is a marketplace that helps businesses in easily hiring and buying furniture, printed displays, floor coverings and more for exhibitions and events by a chain of suppliers. The company has built a customer base of 3500+ companies from 75+ countries. It has a strong supplier network and connections formed with a range of UK event and exhibition suppliers and, it has received a score of 8.5 on TrustPilot. The funds will be used to accelerate product range, strengthen the digital marketing channels and launch new technological platform features.
days to go: Expired investment: £269,841
Captive Media is a technology company that has created a smart way of advertising in mens restrooms. They have installed screens with built-in movement sensors in a number of pubs and clubs all over the the UK. This technology enables the user to for example, play a game handsfree while peeing or watch an interactive advert from a number of different companies. 
days to go: Expired investment: £242,901
A UK based house builder specialising in the delivery of high quality, zero carbon Smart Homes in London and South of England. Verto Homes work with a select handful of experienced property investors, purchasing land sites, redeveloping and ultimately selling new build residential properties through single project, special purpose vehicles. It has developments at various stages of construction with a combined Gross Development Value of over £21m in London and the South West of England. Verto Homes is already making sustainable living a reality with the launch of their zero carbon Smart Homes and the company is now on track to become the UK’s largest sustainable house builder by 2020. http://vertohomes.com/
days to go: Expired investment: £900,000
4solo comply tag enables organisations to automatically record work on properties helping them to keep compliant with all regulations.  They have created smart tags which can be applied to appliances/properties and used alongside their app to track contractors when doing maintenance to properties.  The investment will go towards sales, staff and marketing. (EIS Pending)
days to go: Expired investment: £40,990
Improving the railway construction industry by collecting data to reduce inefficiencies and overspending. Rail Diary is a B2B SaaS product that is designed to analyse information on infrastructure projects to improve particular elements that plague the industry. These include the delivery, commercialisation and the health and safety of projects. Rail Diary allows developers to monitor ongoing costs, forecast for the future and reduce the number of claims made. Rail Diary will generate revenue via a monthly subscription model ranging from £45 to £150, plus project fees.
days to go: Expired investment: £50,544
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph